TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ACIU

AC Immune Ltd

Healthcare · Biotechnology

2.50$ -5.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

AC Immune Ltd (ACIU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 154 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACIU
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
30 80 156 132 197 299 239 261 186 183 231 154
30 79 155 130 193 293 232 203 128 125 172 97
3.3 77 152 124 156 194 161 82 32 78 36 27
3.3 77 152 124 186 289 226 198 123 103 165 91
26 0.3 1.4 3.7 4.1 1.4 1.6 1.0 0.4 15 1.1 1.3
0.3 2.5 0.4 -1.4 0.0 -1.4 -1.9 -1.4 0.0 -0.6 – –
0.6 0.5 1.1 2.4 3.3 6.2 6.6 8.0 7.1 – – –
0.0 0.0 0.0 0.0 0.0 0.0 – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 – 50 50 50 50 50
6.8 8.9 14 15 19 27 23 29 17 22 119 109
4.4 6.1 9.9 9.8 13 18 14 20 11 14 101 95
0.0 0.0 0.0 0.0 0.3 1.1 0.4 0.6 0.5 0.7 1.0 0.9
1.6 1.7 4.0 1.1 2.0 0.1 2.2 2.0 0.9 1.7 2.7 2.1
0.0 0.0 0.0 0.4 0.2 0.0 – – – – – –
23 71 142 117 178 272 215 232 169 161 112 45
-60 -40 -47 -73 -122 -76 -133 -201 -264 -316 -368 -440
55 55 50 57 62 71 72 75 84 85 100 101

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?